Evangelia Chantzara

Larisa, ESYE14 41221, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Peripheral T-Cell Receptor β Repertoire Dynamics Correlate with Response to Anti-PD-L1 Therapy in Non-Small Cell Lung Cancer.

Peripheral T-Cell Receptor β Repertoire Dynamics Correlate with Response to Anti-PD-L1 Therapy in Non-Small Cell Lung Cancer.

Journal: Cancers
Published: May 27, 2026

Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma Patients.

Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma Patients.

Journal: ImmunoTargets and therapy
Published: January 10, 2026

Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Journal: Cancers
Published: December 06, 2025

Profiling of circulating T-cells with prognostic and predictive value in early and advanced stage PDAC.

Profiling of circulating T-cells with prognostic and predictive value in early and advanced stage PDAC.

Journal: Cancer immunology, immunotherapy : CII
Published: June 17, 2025

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Journal: Cancers
Published: May 25, 2024

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach.

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach.

Journal: Molecular oncology
Published: January 30, 2024

Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.

Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.

Journal: Cancers
Published: July 18, 2023

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.

Journal: Biomedicines
Published: September 15, 2022

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.

Journal: Cells
Published: November 17, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026